How are patients undergoing urologic surgery getting narcotics refills?
“We found that a remarkable percentage of patients were getting narcotics refills from non urologists,” said Jay Simhan, MD, FACS.
In this video, Jay Simhan, MD, FACS, discusses the recent Urology study, “Prescribing trends in post-operative pain management after urologic surgery: a quality care investigation for healthcare providers,” for which he served as senior author. Simhan is vice-chairman of the department of urology and director of urologic trauma, reconstruction & prosthetics for the Einstein Healthcare Network, Philadelphia, Pennsylvania.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
